Fycompa 2 MG 2-Week Sample Kit
- RxCUI
- 2641919
- RxNorm name
- Fycompa 2 MG 2-Week Sample Kit
- Display name
- Fycompa 2 MG 2-Week Sample Kit
- Full name
- Fycompa 2 MG 2-Week Sample Kit
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fycompa | PERAMPANEL | Catalyst Pharmaceuticals, Inc. | ec812ea3-de3a-4271-957c-db8f692d1ae3 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 2641919 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | Fycompa 2 MG 2-Week Sample Kit | SY | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | {14 (perampanel 2 MG Oral Tablet [FYCOMPA]) } Pack [Fycompa 2 MG 2-Week Sample Kit] | BPCK | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | Fycompa 2 MG 2-Week Sample Kit | PSN | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |